Takeda Pharmaceutical is Japan's leading pharmaceutical company, focusing on five core therapeutic areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies. With a revenue of JPY 4.6 trillion in fiscal 2024, the company has a well-diversified geographic footprint, with over 50% of its revenue coming from the US.
Board Member and Director - President, Research and Development
Christophe Weber Ph.D
Representative Director-President, CEO and Board Member
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.